Abstract: Three different correction factors for measurements with the parallel-plate ionization chamber PTW T34013 on the Esteya electronic brachytherapy unit have been investigated. This chamber type is recommended by AAPM TG-253 for depth-dose measurements in the 69.5 kV x-ray beam generated by the Esteya unit. Monte Carlo simulations using the PENELOPE-2018 system were performed to determine the absorbed dose deposited in water and in the chamber sensitive volume at different depths with a Type A uncertainty smaller than 0.1%. Chamber-to-chamber differences have been explored performing measurements using three different chambers. The range of conical applicators available, from 10 to 30 mm in diameter, has been explored. Using a depth-independent global chamber perturbation correction factor without a shift of the effective point of measurement yielded differences between the absorbed dose to water and the corrected absorbed dose in the sensitive volume of the chamber of up to 1% and 0.6% for the 10 mm and 30 mm applicators, respectively. Calculations using a depth-dependent perturbation factor, including or excluding a shift of the effective point of measurement, resulted in depth-dose differences of about +/- 0.5% or less for both applicators. The smallest depth-dose differences were obtained when a shift of the effective point of measurement was implemented, being displaced 0.4 mm towards the center of the sensitive volume of the chamber. The correction factors were obtained with combined uncertainties of 0.4% (k = 2). Uncertainties due to chamber-to-chamber differences are found to be lower than 2%. The results emphasize the relevance of carrying out detailed Monte Carlo studies for each electronic brachytherapy device and ionization chamber used for its dosimetry.

Abstract: We consider the possibility that dark energy and baryons might scatter off each other. The type of interaction we consider leads to a pure momentum exchange, and does not affect the background evolution of the expansion history. We parametrize this interaction in an effective way at the level of Boltzmann equations. We compute the effect of dark energy-baryon scattering on cosmological observables, focusing on the cosmic microwave background (CMB) temperature anisotropy power spectrum and the matter power spectrum. Surprisingly, we find that even huge dark energy-baryon cross-sections sigma(xb) similar to O(b), which are generically excluded by non-cosmological probes such as collider searches or precision gravity tests, only leave an insignificant imprint on the observables considered. In the case of the CMB temperature power spectrum, the only imprint consists in a sub-per cent enhancement or depletion of power (depending whether or not the dark energy equation of state lies above or below -1) at very low multipoles, which is thus swamped by cosmic variance. These effects are explained in terms of differences in how gravitational potentials decay in the presence of a dark energy-baryon scattering, which ultimately lead to an increase or decrease in the late-time integrated Sachs-Wolfe power. Even smaller related effects are imprinted on the matter power spectrum. The imprints on the CMB are not expected to be degenerate with the effects due to altering the dark energy sound speed. We conclude that, while strongly appealing, the prospects for a direct detection of dark energy through cosmology do not seem feasible when considering realistic dark energy-baryon cross-sections. As a caveat, our results hold to linear order in perturbation theory.

Abstract: Particle therapy is a highly conformal radiotherapy technique which reduces the dose deposited to the surrounding normal tissues. In order to fully exploit its advantages, treatment monitoring is necessary to minimize uncertainties related to the dose delivery. Up to now, the only clinically feasible technique for the monitoring of therapeutic irradiation with particle beams is Positron Emission Tomography (PET). In this work we have compared a Resistive Plate Chamber (RPC)-based PET scanner with a scintillation-crystal-based PET scanner for this application. In general, the main advantages of the RPC-PET system are its excellent timing resolution, low cost, and the possibility of building large area systems. We simulated a partial-ring scannerbeam monitoring, which has an intrinsically low positron yield compared to diagnostic PET. In addition, for in-beam PET there is a further data loss due to the partial ring configuration. In order to improve the performance of the RPC-based scanner, an improved version of the RPC detector (modifying the thickness of the gas and glass layers), providing a larger sensitivity, has been simulated and compared with an axially extended version of the crystal-based device. The improved version of the RPC shows better performance than the prototype, but the extended version of the crystal-based PET outperforms all other options. based on an RPC prototype under construction within the Fondazione per Adroterapia Oncologica (TERA). For comparison with the crystal-based PET scanner we have chosen the geometry of a commercially available PET scanner, the Philips Gemini TF. The coincidence time resolution used in the simulations takes into account the current achievable values as well as expected improvements of both technologies. Several scenarios (including patient data) have been simulated to evaluate the performance of different scanners. Initial results have shown that the low sensitivity of the RPC hampers its application to hadron